Citigroup
BMRA icon

Citigroup’s Biomerica BMRA Stock Holding History

Citigroup’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,433
Closed -$6.13K – 5963
2025
Q4 		$6.13K Buy
2,433
+1,633
+204% +$4.25K ﹤0.01% 5190
2025
Q3 		$2.26K Buy
+800
New +$2.53K ﹤0.01% 5454

Other funds holding BMRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Citigroup's BMRA Position: Q1 2026 in Review

Citigroup sold out of Biomerica (BMRA) in Q1 2026, closing a stake of 2,433 shares — an estimated $6.13K sold.

Citigroup first reported a position in BMRA in Q3 2025 and held it in 2 quarters. The position peaked at $6.13K in Q4 2025. 11 funds tracked by Wall St. Rank hold BMRA as of Q1 2026.

  • Citigroup reported no remaining Biomerica position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 2,433 Biomerica shares in Q1 2026, an estimated $6.13K.
  • Citigroup first reported a position in Biomerica in Q3 2025 and held it in 2 quarters.
  • Citigroup's Biomerica position peaked at $6.13K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Biomerica as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.